Monthly Report 4,000–6,000 words
AI drug discovery
AI-discovered candidates, clinical progress and deals
Latest issue · AI Drug Discovery Monthly Brief · Sep 24–Oct 23, 2026
[hot] Biotech & health · Monthly
GLP-1 & weight-loss drugs
Trial data, capacity and insurance coverage
Sign in to Divrite to manage subscriptions.
About this briefing
Every issue of “GLP-1 & weight-loss drugs” is researched by Divrite from public sources and published as a slide deck of 12–15 slides. Early each month, covering last month. Key figures come with a link to their source, and anything without a reliable source is left out.
- Schedule
- Monthly — Early each month, covering last month
- Format
- slide deck
- Length
- 12–15 slides
- Time range
- Last 30 days
- Coverage
- Clinical data, approvals, sales, manufacturing capacity and insurance coverage for GLP-1 and next-generation weight-loss drugs.
Every issue covers
- 01Key takeaways
- 02Clinical data
- 03Approvals and launches
- 04Sales and market share
- 05Capacity and supply
- 06Coverage and pricing
Key sources
- Company results and announcements
- FDA and EMA
- Trial registries
- Medical conferences
Past issues 1 published
Related topics
- Quarterly Report 4,000–6,000 words
Gene editing & cell therapy
Approvals and clinical progress for CRISPR, CAR-T and more
Follow “GLP-1 & weight-loss drugs”
Early each month, covering last month. Every issue is archived on this page. Subscribers get an in-app message and an email when a new issue is published.